Stanford Scientists Discover Potential New Parkinson's Treatment

Stanford researchers discovered that inhibiting the overactive enzyme LRRK2 in mice with a genetic mutation related to Parkinson's disease can restore neuron function, suggesting a promising new treatment approach that could benefit multiple Parkinson's patient groups, though further research in humans is needed.